{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:28Z","timestamp":1772160448123,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T00:00:00Z","timestamp":1251936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    The danger hypothesis provides a new perspective of the mechanisms underlying drug allergy. In this study, we evaluated associations between variations in the genes involved in danger signal pathways and antibiotic\u2010induced cutaneous allergic reactions (AICARs).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    Two hundred cases with urticaria, angio\u2010oedema, maculopapular rash, and erythema multiforme caused by antibiotics were extracted from the database of the Adverse Drug Reaction Research Group in Korea. All cases were confirmed by an allergy specialist. Causative antibiotics included penicillin, cephalosporin, quinolone, and others (approximately 40 different types). Ten single nucleotide polymorphisms (SNPs) in seven genes (\u2212318C&gt;T, +49A&gt;G, and +6230G&gt;A in\n                    <jats:italic>CTLA4<\/jats:italic>\n                    , IVS+17T&gt;C in\n                    <jats:italic>CD28<\/jats:italic>\n                    , \u22123479T&gt;G and I170V in\n                    <jats:italic>CD86<\/jats:italic>\n                    , \u22121C&gt;T in\n                    <jats:italic>CD40<\/jats:italic>\n                    , \u22123458A&gt;G in\n                    <jats:italic>CD40LG<\/jats:italic>\n                    , \u2212308G&gt;A in\n                    <jats:italic>TNF<\/jats:italic>\n                    , and \u221231T&gt;C in\n                    <jats:italic>IL1B<\/jats:italic>\n                    ) were scored for cases and for healthy subjects without a history of AICARs.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    Our analysis failed to reveal differences in the distribution of the 10 SNPs between cases and controls. However, we could find a gene\u2013gene interaction between \u22121C&gt;T in\n                    <jats:italic>CD40<\/jats:italic>\n                    and \u22123458A&gt;G in\n                    <jats:italic>CD40L<\/jats:italic>\n                    using multifactor dimensionality reduction analysis. Subjects with minor alleles of both SNPs showed a significant risk for developing AICARs [\n                    <jats:italic>P<\/jats:italic>\n                    =0.017, odds ratio (OR) (95% confidence interval)=2.93 (1.20\u20137.97)].\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    Our findings suggest that a genetic interaction between\n                    <jats:italic>CD40<\/jats:italic>\n                    and\n                    <jats:italic>CD40L<\/jats:italic>\n                    favours the development of AICARs.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2222.2009.03336.x","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T23:34:04Z","timestamp":1252020844000},"page":"1852-1856","source":"Crossref","is-referenced-by-count":10,"title":["Allelic variants of CD40 and CD40L genes interact to promote antibiotic\u2010induced cutaneous allergic reactions"],"prefix":"10.1111","volume":"39","author":[{"given":"Sae\u2010H","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u2010E","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang\u2010H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u2010K","family":"Jee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u2010K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u2010S","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u2010U","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u2010W","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Adverse Drug Reaction Research Group in Korea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,11,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.12.040194.005015"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118509"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(02)00255-X"},{"key":"e_1_2_6_5_2","first-page":"387","article-title":"New concepts in immunology relevant to idiosyncratic drug reactions","volume":"12","author":"Uetrecht J.","year":"1999","journal-title":"the \u201cDanger Hypothesis\u201d and innate immune system"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)91893-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03720080019021"},{"key":"e_1_2_6_8_2","first-page":"1393","article-title":"Severe neutropenia associated with procainamide","volume":"109","author":"Meyers DG","year":"1985","journal-title":"comparison of sustained and conventional preparations"},{"key":"e_1_2_6_9_2","first-page":"1249","article-title":"Natural adjuvants","volume":"5","author":"Gallucci S","year":"1999","journal-title":"endogenous activators of dendritic cells"},{"key":"e_1_2_6_10_2","first-page":"114","article-title":"Danger signals","volume":"13","author":"Gallucci S","year":"2001","journal-title":"SOS to the immune system"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.260497597"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.6.3256"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00003"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02820.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.9.1229"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12065.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.6.3837"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02742.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00130832-200308000-00001"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90198-G"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07023.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01774.x"},{"key":"e_1_2_6_23_2","first-page":"423","article-title":"Consequences of cell death","volume":"191","author":"Sauter B","year":"2000","journal-title":"exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.12.019"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5533"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200609-1286OC"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000222908.78873.36"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2009.03336.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2009.03336.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:51:42Z","timestamp":1697413902000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2009.03336.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,13]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1365-2222.2009.03336.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03336.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1281961.748061","asserted-by":"object"}]},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,13]]}}}